Literature DB >> 22372228

Influenza-related pneumonia.

Mark H Almond1, Danny F McAuley, Matt P Wise, Mark J D Griffiths.   

Abstract

Influenza-related pneumonia encompasses both primary viral pneumonia and secondary bacterial pneumonia, which may be difficult to differentiate clinically. A high index of suspicion, prompt initiation of antiviral and antibiotic therapy, and appropriate escalation to secondary/critical care are key to improving outcome.

Entities:  

Mesh：

Year:  2012        PMID： 22372228      PMCID： PMC4953425          DOI： 10.7861/clinmedicine.12-1-67

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


  16 in total

Review 1.  Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.

Authors:  Edgar Bautista; Tawee Chotpitayasunondh; Zhancheng Gao; Scott A Harper; Michael Shaw; Timothy M Uyeki; Sherif R Zaki; Frederick G Hayden; David S Hui; Joel D Kettner; Anand Kumar; Matthew Lim; Nahoko Shindo; Charles Penn; Karl G Nicholson
Journal:  N Engl J Med       Date:  2010-05-06       Impact factor: 91.245

2.  Impact of the 2009 influenza pandemic.

Authors:  J Dunning; P J M Openshaw
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

3.  Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health.

Authors: 
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

4.  When to consider the use of antibiotics in the treatment of 2009 H1N1 influenza-associated pneumonia.

Authors:  Peter F Wright; Kathryn B Kirkland; John F Modlin
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

Review 5.  The innate immune rheostat: influence on lung inflammatory disease and secondary bacterial pneumonia.

Authors:  Tracy Hussell; Mary M Cavanagh
Journal:  Biochem Soc Trans       Date:  2009-08       Impact factor: 5.407

6.  Comparison of combined nose-throat swabs with nasopharyngeal aspirates for detection of pandemic influenza A/H1N1 2009 virus by real-time reverse transcriptase PCR.

Authors:  Victoria Ortiz de la Tabla; Mar Masiá; Pedro Antequera; Coral Martin; Gregoria Gazquez; Fernando Buñuel; Félix Gutiérrez
Journal:  J Clin Microbiol       Date:  2010-08-11       Impact factor: 5.948

Review 7.  Insights into the interaction between influenza virus and pneumococcus.

Authors:  Jonathan A McCullers
Journal:  Clin Microbiol Rev       Date:  2006-07       Impact factor: 26.132

8.  Pulmonary pathologic findings of fatal 2009 pandemic influenza A/H1N1 viral infections.

Authors:  James R Gill; Zong-Mei Sheng; Susan F Ely; Donald G Guinee; Mary B Beasley; James Suh; Charuhas Deshpande; Daniel J Mollura; David M Morens; Mike Bray; William D Travis; Jeffery K Taubenberger
Journal:  Arch Pathol Lab Med       Date:  2010-02       Impact factor: 5.534

Review 9.  Complications of seasonal and pandemic influenza.

Authors:  Michael B Rothberg; Sarah D Haessler
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

10.  Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.

Authors:  Seema Jain; Laurie Kamimoto; Anna M Bramley; Ann M Schmitz; Stephen R Benoit; Janice Louie; David E Sugerman; Jean K Druckenmiller; Kathleen A Ritger; Rashmi Chugh; Supriya Jasuja; Meredith Deutscher; Sanny Chen; John D Walker; Jeffrey S Duchin; Susan Lett; Susan Soliva; Eden V Wells; David Swerdlow; Timothy M Uyeki; Anthony E Fiore; Sonja J Olsen; Alicia M Fry; Carolyn B Bridges; Lyn Finelli
Journal:  N Engl J Med       Date:  2009-10-08       Impact factor: 91.245
View more
  5 in total

1.  Anti-Inflammatory Mechanisms of Total Flavonoids from Mosla scabra against Influenza A Virus-Induced Pneumonia by Integrating Network Pharmacology and Experimental Verification.

Authors:  Wei Cai; Shui-Li Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-08       Impact factor: 2.650

2.  Neuraminidase-producing oral mitis group streptococci potentially contribute to influenza viral infection and reduction in antiviral efficacy of zanamivir.

Authors:  Noriaki Kamio; Kenichi Imai; Kazufumi Shimizu; Marni E Cueno; Muneaki Tamura; Yuko Saito; Kuniyasu Ochiai
Journal:  Cell Mol Life Sci       Date:  2014-07-08       Impact factor: 9.261

3.  Association of Consecutive Influenza Vaccinations and Pneumonia: A Population-Based Case-Control Study.

Authors:  Liang-Tsai Yeh; Chi-Ho Chan; Shun-Fa Yang; Han-Wei Yeh; Ying-Tung Yeh; Yu-Hsun Wang; Ming-Chih Chou; Chao-Bin Yeh; Ying-Hock Teng
Journal:  Int J Environ Res Public Health       Date:  2019-03-26       Impact factor: 3.390

4.  FluA-p score: a novel prediction rule for mortality in influenza A-related pneumonia patients.

Authors:  Liang Chen; Xiudi Han; Yan Li Li; Chunxiao Zhang; Xiqian Xing
Journal:  Respir Res       Date:  2020-05-08

5.  Factors Affecting the Incidence of Hospitalized Pneumonia after Influenza Infection in Korea Using the National Health Insurance Research Database, 2014-2018: Focusing on the Effect of Antiviral Therapy in the 2017 Flu Season.

Authors:  Kyeong Hyang Byeon; Jaiyong Kim; Bo Youl Choi; Jin Yong Kim; Nakyoung Lee
Journal:  J Korean Med Sci       Date:  2020-09-28       Impact factor: 2.153
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.